DeepVerge plc confirmed that analysis to investigate the detection of SARS-CoV-2 virus on Microtox®PD chips coated with Optimers[i], binding agents provided by Aptamer Group plc has detected 3 common variants of concern of SARS-CoV-2 virus. Modern Water Mobile Services[ii] (RNS December 10, 2021), due to launch later this quarter, will have Compact Microtox®PD units with the ability to test for all 3 variants to detect and quantify the spready of COVID-19 in the community. Scientists at the York, UK, Laboratory, have successfully populated the binding agents on the chips using an anti-SARS-CoV-2 antibody, that was raised against the Alpha variant.

While variation of detection of all 3 variants was observed, both Delta and Omicron variants had a higher affinity to the Optimer coated chips than Alpha. The Company believes these results validate the expansion of the York facilities to accommodate containment level 3 to work on dangerous pathogens, which include SARS-CoV-2.